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ABSTRACT: The aggregation of α-synuclein, a protein
involved in neurotransmitter release at presynaptic terminals,
is associated with a range of highly debilitating neuro-
degenerative conditions, most notably Parkinson’s disease.
Intraneuronal inclusion bodies, primarily composed of α-
synuclein fibrils, are the major histopathological hallmarks of
these disorders, although small oligomeric assemblies are
believed to play a crucial role in neuronal impairment. We
have probed the mechanism of neurotoxicity of α-synuclein
oligomers isolated in vitro using antibodies targeting the N-
terminal region of the protein and found that the presence of
the antibody resulted in a substantial reduction of the damage
induced by the aggregates when incubated with primary cortical neurons and neuroblastoma cells. We observed a similar
behavior in vivo using a strain of C. elegans overexpressing α-synuclein, where the aggregation process itself is also partially
inhibited as a result of incubation with the antibodies. The similar effects of the antibodies in reducing the toxicity of the
aggregated species formed in vitro and in vivo provide evidence for a common origin of cellular impairment induced by α-
synuclein aggregates.
α-Synuclein (αS) is an intrinsically disordered protein with a
molecular weight of 14 kDa whose aggregation and conversion
into amyloid fibrils is associated with a range of highly
debilitating neurodegenerative disorders, including Parkinson’s
disease (PD), Parkinson’s disease with dementia (PDD),
dementia with Lewy bodies (DLB), and multiple system
atrophy (MSA).1−3 Fibrillar aggregates of αS have been
identified as the major constituents of the proteinacious
inclusions known as Lewy bodies that form inside the neurons
of patients suffering from these conditions,4,5 and a number of
missense mutations, as well as duplications and triplications of
the gene encoding αS, are associated with familial forms of
early onset PD.6−8 Because of the link between αS aggregation
and PD, intensive efforts have been expended to characterize
the structural properties of its fibrillar form,9−16 although it has
become evident both in vitro6,17−22 and in vivo23,24 that smaller
αS oligomers are likely to be the crucial species associated with
the underlying mechanism of neurotoxicity. A number of αS
oligomeric species have been described so far, providing
evidence of the toxicity of these highly heterogeneous
species.25−27
The general mechanism of aggregation of αS has been
characterized in vitro,28 although the detailed description of the
oligomeric species populated during the aggregation process
has proved to be challenging, primarily because of the
difficulties in studying the structural properties of the often
short-lived and highly heterogeneous oligomeric intermediates
that are populated prior to the formation of well-defined
amyloid fibrils.29 This objective is, however, of vital importance
in the quest to define the underlying molecular origins of
neurodegenerative conditions associated with αS aggregation.
Several lines of evidence have indicated that interactions of αS
oligomers with biological membranes, resulting in the loss of
cellular or subcellular integrity, are key elements that promote
neuronal toxicity.20,23,30−34 In addition, we have observed that
natural aminosterol molecules that disrupt binding of αS to
cellular membranes, namely, squalamine and trodusquemine,
reduce its toxicity in both cells and in a C. elegans model of αS
toxicity in vivo.35,36
In the present study, we used an antibody that targets the N-
terminal region of αS to probe the mechanism of toxicity of its
oligomers when incubated with primary cortical neurons and
cultured neuroblastoma cells. The presence of the antibody
induced a reduction of the toxicity of the αS oligomers,
thereby supporting the role of the N-terminal region of the
protein in the mechanism of membrane disruption that
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generates cellular toxicity.17 We also probed the effect of the
antibody in C. elegans animals overexpressing αS, showing a
reduction of the aggregation of αS and locomotor impairment
in the worms. The finding that the nature of the reduction in
toxicity of αS oligomers by this antibody in vitro is similar in
the C. elegans model provides evidence for a common
mechanism of toxicity induced by αS aggregates, whether
these are oligomers isolated in vitro or are the species formed in
vivo by aggregation in C. elegans.
■ RESULTS
Effects of Primary Antibodies on the Membrane
Disruption by αS Oligomers. Toxic αS oligomers were
formed as previously reported19 and are defined as type B*
oligomers.17 According to previous findings,17,20−22 incubation
of the type B* αS oligomers with healthy neuronal cells was
found to induce cellular damage, resembling the pathophysio-
logical effects observed in pluripotent stem cell-derived
neurons from a PD patient with triplication of the αS
gene.37 These effects included significant increases in the level
of basal intracellular Ca2+ and of intracellular reactive oxygen
species (ROS), as well as damage to mitochondrial function
and disruption of cellular membranes.17 We identified in a
previous study two key elements responsible for the generation
of neuronal damage by toxic αS oligomers; these are an
exposed highly lipophilic element, found to be the disordered
N-terminal region of the protein (residues 1−25), and a highly
structured core, identified as residues 70−87, that is rich in β-
sheet structure.17 The oligomers interact with lipid bilayers
such that the otherwise disordered N-terminal region of the
protein adopts an amphipathic helical conformation that
anchors the αS oligomers to the membrane surfaces, while
the highly structured regions of the assembly insert into the
interior of the bilayers thereby disrupting their integrity
(Figure 1A). In addition to these structural features that are
characteristic of the toxic oligomeric species of αS, the
oligomers expose the negatively charged and disordered C-
terminus of the protein (residues 100−140), which does not,
however, play a role in the mechanism of toxicity by these
oligomers.17
In the present study, we made use of a primary antibody,
obtained by rabbit immunization against a peptide encompass-
ing the 25 N-terminal residues of αS (designated as Nt-Ab, see
Methods). We found that its addition to solutions containing
the αS oligomers rescued the disruption of cellular viability
caused by these aggregates, as probed using primary rat cortical
neurons and human SH-SY5Y neuroblastoma cells. We first
monitored the effects of the presence of Nt-Ab on the ability of
the toxic αS oligomers to disrupt the plasma membrane of
both neuronal cell types, using calcein-loaded cells and
monitoring the efflux of the fluorescent calcein dye from the
cytosol to the external medium (Figure 1B, C). Following
incubation of the cells with αS oligomers at a concentration of
0.3 μM (monomer equivalents) in the absence of Nt-Ab for 1
h, a reduction of the calcein-derived fluorescence of ca. 70%
was observed in both the primary cortical neurons and the
neuroblastoma cells, indicating in both cases that the oligomers
induce significant disruption of cellular membranes (Figure 1B,
C). In the presence of Nt-Ab at a 1:1 molar ratio of αS:Nt-Ab,
however, such disruption was almost completely inhibited, as
the intracellular calcein-associated fluorescence was found to
be restored almost to that of untreated cells (Figure 1B, C). By
contrast, analogous experiments carried out in the presence of
Figure 1. Membrane disruption by αS oligomers and its suppression
by Nt-Ab. (A) Model of toxic αS oligomers,17 showing the lipophilic
exposed N-terminal region of the protein (blue), and a core region
that is rich in β-sheet structure (red). These elements have a role in
the mechanisms by which toxic αS oligomers disrupt biological
membranes. In particular, upon membrane binding, the N-terminal
region of αS adopts an amphipathic α-helical conformation that
anchors the oligomers to the membrane surface whereas the
structured core inserts into the interior of the lipid bilayer and
disrupts its integrity. The scheme shows how binding of Nt-Ab (red
and yellow chains) to the N-terminal region of αS inhibits the key
initial step promoting membrane binding and disruption. (B)
Representative confocal scanning microscopy images of primary
cortical neurons (upper panels) and SH-SY5Y cells (lower panels),
illustrating the degree of intracellular calcein-induced fluorescence in
the two types of cells upon incubation with 0.3 μM (monomer
equivalents) αS oligomers in the absence or presence of 1:1 molar
ratio of Ct-Ab or Nt-Ab. (C) Quantification of the green fluorescent
signal arising from the calcein probe. Error bars indicate the SEM; **
and *** indicate p values ≤ 0.01 and ≤ 0.001 calculated with respect
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a primary antibody targeting the C-terminal region, spanning
residues 126 to 140 of αS and designated as Ct-Ab (see
Methods), resulted in moderate changes in the degree of
membrane disruption (ca. 30% and 50% for SH-SY5Y and
primary neurons, respectively, Figure 1B,C). This observation
is likely to be attributable to steric effects on the interaction of
the oligomers with the cell membrane resulting from the
binding of Ct-Ab to the C-terminal region of the protein.
Figure 1. continued
to the data measured on untreated cells (n = 6 per group); §, §§, and
§§§ indicate respectively p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001 calculated
with respect to the data measured on cells treated with toxic
oligomers (n = 6 per group). Samples were analyzed by one-way
ANOVA followed by Bonferroni’s multiple comparison test relative to
untreated cells. A total of 80−120 cells were analyzed per condition in
total in three independent experiments.
Figure 2.Membrane binding by αS oligomers. (A) Representative confocal scanning microscopy images of primary cortical neurons (upper panels)
and SH-SY5Y cells (lower panels) under the experimental conditions indicated. Red and green fluorescence indicates the cell membranes and αS
oligomers, respectively. (B) Degree of membrane binding by αS oligomers measured following their incubation with primary cortical neurons and
human SH-SY5Y neuroblastoma cells using 0.3 μM (monomer equivalents) αS oligomers in the absence or presence of 1:1 molar ratios of Ct-Ab
or Nt-Ab. (C, D) Representative confocal scanning microscopy images (C) and quantification analysis (D) of SH-SY5Y cells treated with 0.3 μM
(monomer equivalents) αS oligomers in the absence or presence of Nt-Ab at αS:Ab molar ratios of 1:0.1, 1:0.25, 1:0.5, and 1:1, where molar ratios
always refer to monomer equivalents. In panel A, αS oligomers alone and in the presence of Ct-Ab were detected using 1:250 diluted rabbit
polyclonal anti-αS antibodies, whereas αS oligomers in the presence of Nt-Ab were detected with 1:250 diluted mouse monoclonal anti-αS IgG1. In
panel C, αS oligomers alone and in the presence of Nt-Ab were detected using 1:250 diluted mouse monoclonal anti-αS IgG1 antibodies (Santa
Cruz Biotechnology, Santa Cruz, CA, USA). (E,F) Representative confocal scanning microscopy images (E) and quantification analysis (F) of
primary rat cortical neurons treated with 0.3 μM (monomer equivalents) AF488 αS oligomers in the absence or presence of 1:1 molar ratios of Ct-
Ab or Nt-Ab. In panels B, D, and F, the error bars indicate the SEM, ** and *** indicate p values ≤0.01 and ≤0.001 calculated with respect to the
data for untreated cells (n = 6 per group), § and §§§ indicate respectively p ≤ 0.05 and p ≤ 0.001 calculated with respect to the data for cells
treated with toxic oligomers (n = 6 per group). Samples were analyzed by one-way ANOVA followed by Bonferroni’s multiple comparison test
relative to untreated cells. A total of 80−120 cells were analyzed per condition in total in three independent experiments.
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Effects of Primary Antibodies on the Interaction of
αS Oligomers with Membranes. We then examined
whether or not the addition of Nt-Ab to the toxic αS
oligomers resulted in the reduction of the binding affinity of
the oligomers to cellular membranes. Confocal images of
primary cortical neurons and neuroblastoma cells following
incubation for 15 min with the toxic αS oligomers showed
strong colocalization of the aggregates with the plasma
membrane of both types of cells (Figure 2A, B). When the
αS oligomers were incubated with the two types of cells in the
presence of Nt-Ab, however, the colocalization with the plasma
membrane was essentially completely abolished (Figure 2A,
B). By contrast, the addition of Ct-Ab reduced to a lower
extent (ca. 60% and 50% for primary neurons and SH-SY5Y
cells, respectively) the ability of the toxic αS oligomers to
colocalize with cellular membranes (Figure 2A, B). The affinity
of αS oligomers for cellular membranes was also probed by
using a range of concentrations of Nt-Ab (0.03 μM to 0.3 μM)
and a constant level of αS oligomers (0.3 μM; Figure 2C, D).
The experiments showed a significant reduction in membrane
binding by the oligomers even at an αS:Nt-Ab molar ratio of
1:0.5, with only marginal effects found at lower Nt-Ab
concentrations (Figure 2C, D). The inhibition of oligomer
binding by Nt-Ab was also confirmed with neuroblastoma cells
by using oligomers formed by 10% of αS labeled with AF488
dye at the residue 122 (Figure 2E, F).
Taken together, these data indicate that by targeting the N-
terminal region of αS using antibodies, it is possible to
suppress almost completely the interaction of toxic aggregates
with cellular membranes and hence to avoid the consequent
disruption of the membrane integrity. This result is consistent
with our previous mutational analysis, which showed that the
toxicity of αS oligomers can be reduced significantly by
modifying the sequence of the N-terminal region of αS.17
Effects of Primary Antibodies on Mitochondrial
Activity. We then assessed if the presence of Nt-Ab can
reduce the downstream effects arising from the incubation of
neuronal cells with toxic αS oligomers, including impairment
of mitochondrial activity. The results showed that the αS
oligomers (0.3 μM) generated in vitro reduced substantially the
mitochondrial activity of both primary cortical neurons (Figure
3A) and neuroblastoma cells (Figure 3B), as probed by the
reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT). MTT reduction was almost fully
restored at a 1:1 molar ratio of αS:Nt-Ab, both in primary
neurons (Figure 3A) and in neuroblastoma cells (Figure 3B),
with very minor effects observed at 1:0.5 or lower molar ratios.
By contrast, incubation of the oligomers with different
concentrations of Ct-Ab resulted in very modest improvements
of the mitochondrial activity in both cell lines even at a 1:1
molar ratio (Figure 3A,B).
Effects of Primary Antibodies on the Generation of
Intracellular Reactive Oxygen Species. Since a rise in the
levels of oxidative stress has been reported to be an important
feature in PD,21 we also analyzed the generation of reactive
oxygen species (ROS) in neuroblastoma cells under the
various conditions explored for the other examined toxicity
readouts. In particular, toxic αS oligomers were found to
induce a large increase (nearly 4-fold relative to untreated
cells) in intracellular ROS levels (Figure 3C,D).17 A very
significant reduction of intracellular ROS generation was,
however, observed following incubation of the oligomers with
Nt-Ab at a 1:1 molar ratio, with the levels of ROS being
Figure 3.Measurements of the cellular toxicity of αS oligomers. (A,B)
Mitochondrial activity monitored by the reduction of MTT, measured
for rat primary cortical neurons (A) and human neuroblastoma SH-
SY5Y cells (B) upon incubation with 0.3 μm αS oligomers (monomer
equivalents), in the absence or presence of Nt-Ab or Ct-Ab at αS/Ab
molar ratios of 1:0.1, 1:0.25, 1:0.5 and 1:1, where molar ratios always
refer to monomer equivalents. (C) Intracellular ROS production in
SH-SY5Y cells resulting from incubation with 0.3 μM (monomer
equivalents) αS oligomers in the absence or presence of a 1:1 molar
ratio of Ct-Ab or Nt-Ab. The images are representative of those
obtained with confocal scanning microscopy under various exper-
imental conditions. The green fluorescence arises from intracellular
ROS. In both panels, the error bars indicate the SEM; *, **, and ***
indicate p values ≤ 0.05, ≤ 0.01, and ≤ 0.001 calculated with respect
to the data measured on untreated cells; §§ and §§§ indicate,
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restored almost to the values of untreated cells (Figure 3C,D).
By contrast, analogous experiments with Ct-Ab resulted in the
intracellular production of ROS in neuroblastoma cells
remaining very high, indicating that the presence of Ct-Ab
generates only a slight reduction of oxidative stress (Figure
3C,D). Taken together, these data indicate that targeting the
N-terminal region of αS oligomers by Nt-Ab results in the
potent suppression of the neurotoxicity of these aggregates, in
contrast to the small effects arising from targeting the C-
terminal region with Ct-Ab.
Structural Analysis of Toxic Oligomers in the
Presence of N-Terminal Antibody. The evidence described
above suggests that Nt-Ab either blocks the interaction
between αS oligomers and the cell membrane or promotes a
structural reorganization (or disaggregation) of the oligomers
by interacting with the exposed N-terminus. Thus, we assessed
whether the structural properties of the β-sheet core and
solvent-exposed hydrophobicity of the αS oligomers were
perturbed by Nt-Ab using Thioflavin T (ThT) fluorescence
and 1-anilino-8-naphthalenesulfonate (ANS) fluorescence,
respectively. Using ThT staining, we observed that αS
oligomers present a rudimentary β-sheet core, as revealed by
the weak increase of ThT fluorescence (Figure 4A). An
equimolar concentration of free Nt-Ab also increased weakly
the fluorescence of ThT, most probably because of its large
content of β-sheet structure in the native state (Figure 4A).
The oligomers preincubated with Nt-Ab produced a higher
increase of ThT fluorescence, as both species contribute to
ThT binding (Figure 4A). The obtained blank-subtracted
spectrum is similar to that determined from the sum of the
blank-subtracted spectra obtained with free Nt-Ab and free
oligomers (or slightly lower as the complex formation
inevitably masks ThT binding sites).
αS oligomers in the absence or presence of an equimolar
ratio of Nt-Ab induced a high ANS fluorescence intensity and a
virtually identical blue-shift of the wavelength of maximum
ANS emission (Figure 4B). Our data indicate that the
tinctorial properties and the degree of hydrophobic-exposed
surfaces of αS oligomers are not affected by Nt-Ab in vitro,
ruling out a significant structural reorganization or a
disassembly of the oligomers by Nt-Ab.
Mechanism of Toxicity in a C. elegans Model of αS-
Mediated Dysfunction. Finally, in this study, we extended
our analysis of the inhibition of αS aggregation and toxicity by
investigating the effects of Nt-Ab and Ct-Ab in a C. elegans
model of αS-mediated dysfunction.35 In this model, nematode
worms were engineered to overexpress αS, tagged with the
yellow fluorescent protein (YFP), in their large muscle
cells.38−40 This specific C. elegans model of αS toxicity has
been instrumental in identifying genes and pathways
connected with the onset and progression of PD38−40 and in
characterizing the inhibition by naturally occurring amino-
sterols of the aggregation and toxicity of αS in vivo.35,36
As a result of the overexpression of YFP-αS, significant
quantities of aggregates were observed to be deposited in the
worms, as shown by fluorescence microscopy (Figure 5A, see
Methods). The extent of YFP-αS aggregation determined from
the images was, however, observed to be significantly reduced
(by ca. 70%) in YFP-αS worms incubated with 0.4 μM Nt-Ab
administered in the worm medium since day 0 of adulthood
(Figure 5A,B); by contrast, the reduction of YFP-αS aggregates
was marginal (ca. 15%) in YFP-αS C. elegans treated with 0.4
μM Ct-Ab. These data provide strong evidence to support the
conclusion that the N-terminal region of αS plays a critical role
in defining the underlying mechanism of the formation of
aggregates. Indeed, this process has been shown to be
promoted by the interaction of αS monomers with
membranes.36,41−43 It is also possible, however, that Nt-Ab is
also able to inhibit the formation of fibrils by binding to small
aggregates, including oligomeric species, of αS and preventing
their conversion into fibrillar species that are able to elongate.
In addition to reducing the extent of aggregation as a result of
the treatment with Nt-Ab, we observed the almost complete
suppression of the ability of the aggregates to cause motility
impairment in the animals. In particular, untreated YFP-αS
Figure 3. continued
respectively, p ≤ 0.01 and p ≤ 0.001 calculated with respect to the
data measured on cells treated with toxic oligomers (n = 9 and n = 6
per group for MTT and ROS, respectively). Samples were analyzed by
one-way ANOVA followed by Bonferroni’s multiple comparison test
relative to untreated cells. A total of 80 000−120 000 cells for MTT
and 80−120 cells for ROS were analyzed per condition in total in
three independent experiments.
Figure 4. Structural characterization of αS oligomers in the absence
and presence of Nt-Ab. (A) ThT fluorescence spectra of αS oligomers
(4 μM) incubated in the absence (red) or presence (blue) of a 1:1
molar ratio of Nt-Ab for 15 min before performing the measurement.
The ThT fluorescence spectra of free Nt-Ab (green) and without any
protein (dashed line) are also shown. Samples were excited at 440
nm, and the emission fluorescence spectra were recorded between
460 and 600 nm. (B) ANS fluorescence spectra of αS oligomers (4
μM) incubated in the absence or presence of a 1:1 molar ratio of Nt-
Ab for 15 min before performing the measurement. The ANS
fluorescence spectrum without any protein is also shown (dashed
line). Samples were excited at 350 nm, and the emission fluorescence
spectra were recorded between 400 and 650 nm.
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animals show a very significant reduction in their motility
properties, measured as bends per minute in an automated
tracking device (see Methods), compared to control worms
overexpressing YFP alone (Figure 5C). By administering 0.4
μM Nt-Ab in the medium, we observed an essentially complete
recovery of the motility of the YFP-αS C. elegans to the levels
of healthy YFP controls (Figure 5C). By contrast, no
significant improvements in motility were detected as a result
of the treatment with Ct-Ab (Figure 5C).
We also employed a different protocol to administer Nt-Ab
and Ct-Ab to YFP-αS C. elegans. This protocol was developed
to facilitate the ingestion and cell uptake of proteins and
peptides in the worms by encapsulating the biomolecules into
cationic lipid vesicles.44 Antibodies administered in this way
were shown to colocalize with intracellular protein aggregates
formed in YFP-αS C. elegans.44 The results obtained with the
vesicle encapsulation protocol confirmed that Nt-Ab and Ct-
Ab have different effects on the health status of YFP-αS C.
elegans (Figure 5D). In particular, five indicators of worm
health showed a significant improvement of the fitness status of
the YFP-αS C. elegans upon administration of Nt-Ab, in
contrast to very minor effects associated with the utilization of
Ct-Ab.
Overall, the antibody appears to have a double action against
the effects of overexpression of αS in vivo, as it reduces
significantly the extent of aggregation of the protein in C.
elegans and also suppresses the ability of the residual aggregates
that are formed in the worms to impair the locomotor abilities
of the animals. The rescuing effect of Nt-Ab in the C. elegans
experiment resembles that obtained with aminosterols35,36
despite a significant difference in their mechanism of action:
binding to the membrane with consequent displacement of the
oligomers in the case of aminosterols and binding to the
oligomers resulting in inhibition of the interaction with the
membrane in the case of Nt-Ab. These findings suggest that
these two different effects act together to inhibit the key steps
for the generation of toxicity following overexpression of αS in
C. elegans. Moreover, these data indicate that the biological
properties of isolated αS oligomers generated in vitro correlate
well with the behavior of the species that are formed in vivo in
a living organism.
■ DISCUSSION
There is increasing evidence that the disruption of cell
membranes by misfolded protein aggregates is a key step in
the induction of the downstream loss of neuronal viabil-
ity.17,27−29,45,46 The interaction between membranes and
monomeric αS is also crucial for both function47,48 and
aggregation.45,49 In this study, we have provided evidence that
aggregates formed both in vitro and in vivo by αS are able to
induce damage to cells by membrane disruption. In addition,
using antibodies we show that the N-terminal region of αS is a
crucial structural element in the generation of toxicity, both by
stabilized oligomers generated in vitro and through the
formation and toxicity of the aggregates generated in vivo in
C. elegans. The employment of antibodies to target prefibrillar
Figure 5. Effect of Nt-Ab and Ct-Ab on the aggregation and toxicity of αS in C. elegans. (A) Representative fluorescence microscopy images of
worms at day 11 of adulthood expressing YFP (left) or YFP-αS (right) in the absence (top) or presence of 0.4 μM of Ct-Ab (middle) or Nt-Ab
(bottom). The inclusions are indicated by white arrows. (B) Estimates of the number of YFP-αS inclusions in worms in the absence and presence
of 0.4 μM Ct-Ab or Nt-Ab; the error bars indicate the SEM. (C) Effects of Ct-Ab and Nt-Ab on the behavior of the worms overexpressing YFP-αS.
The motilities measured in bends per minute are reported for control animals overexpressing YFP (dotted lines) and YFP-tagged αS (solid lines).
Experiments were performed in the absence (red) or presence of 0.4 μM of Ct-Ab (green) or Nt-Ab (blue), and the error bars indicate the SEM
(D) Fingerprint map64 probing different parameters of the fitness of YFP-αS C. elegans in the absence (red) or presence of 0.4 μM of Ct-Ab (green)
or Nt-Ab (blue). Experiments performed in panels A−C were performed by direct incubation of Nt-Ab and Ct-Ab in the worm medium, whereas
experiments in panel D were performed with the vesicle encapsulation method.44
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protein oligomers, including αS species,50,51 has generated
encouraging results.52,53
In previous work, we have shown that toxic oligomers of αS
can be formed by the structural rearrangement of initially
disordered and nontoxic aggregates, resulting in the formation
of oligomeric species characterized by a structured core rich in
β-sheet conformation and exposed hydrophobic regions.18
Two structural features of the αS toxic oligomers were shown
to be necessary to enable them to disrupt biological
membranes, namely, the presence of a highly lipophilic N-
terminal region of the protein promoting strong interactions
with the membrane surface and the existence of a rigid core
region rich in β-sheet structure that is able to insert into the
lipid bilayer and cause a loss of membrane integrity.17
In the present study, we assessed the origin of the neuronal
toxicity generated by αS oligomers isolated in vitro by using
Nt-Ab, a specific antibody that interacts with the exposed N-
terminal sequence of the protein. The results show that the
antibody restores the normal viability of cultured primary
cortical neurons or neuronal cells incubated in the presence of
the oligomers by inhibiting their interaction with the plasma
membranes of the cells, therefore avoiding the disruption of
the membranes and/or alteration of the protein components
that result in the generation of intracellular ROS and the
impairment of mitochondrial activity. In addition, the presence
of Nt-Ab was found to reduce significantly the formation of
aggregates induced by the overexpression of αS in C. elegans, a
process that is itself related to the interaction of monomeric αS
with cell membranes. Thus, inhibition of aggregation, in
conjunction with suppression of the deleterious effects of any
aggregates that do form, restores the behavioral properties of
the worms to those characteristic of wild-type controls. The
observed reduction in locomotor impairment is particularly
significant because the aggregation of αS in a living system
such as C. elegans is likely to be associated with a highly
heterogeneous ensemble of aggregated states of the protein.1
Yet, the toxicity of these multiple species is suppressed by the
antibody as effectively as that of the highly homogeneous
oligomers generated in vitro.
In conclusion, we have provided experimental evidence for a
common molecular mechanism inducing membrane disruption
by oligomeric species formed by the aggregation of αS in vitro
and in vivo. It is likely that there are other factors that
contribute to cellular toxicity, including the interaction with
other cellular components,54,55 but the similarity of the
behavior of the aggregated species generated under a variety
of conditions provides support for the ability of in vitro systems
to provide detailed mechanistic information that is relevant for
living systems.
■ MATERIALS AND METHODS
αS Purification. αS was expressed and purified in E. coli using
plasmid pT7-7 encoding for the protein.56 After transforming in BL21
(DE3)-gold cells (Agilent Technologies, Santa Clara, CA USA), αS
was obtained by growing the bacteria at 37 °C under constant shaking
at 250 rpm in lysogeny broth (LB) medium supplemented with 100
μg·mL−1 of ampicillin to an OD600 of 0.6. Subsequently the expression
of the protein was induced with 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 37 °C for 4 h, and the cells were
harvested by centrifugation at 6200g (Beckman Coulter, Brea, CA
USA). The cell pellets were resuspended in lysis buffer (10 mM Tris-
HCl pH 8, 1 mM EDTA) and EDTA-free complete protease inhibitor
cocktail tablets (Roche, Basel, Switzerland) and lysed by sonication.
The cell lysate was centrifuged at 22 000g for 30 min, and the
supernatant was heated for 20 min at 70 °C and centrifuged again at
22 000g. Subsequently, streptomycin sulfate was added to the
supernatant to a final concentration of 10 mg·mL−1. The mixture
was stirred for 15 min at 4 °C followed by further centrifugation at
22 000g. Then, ammonium sulfate was added to the supernatant to a
concentration of 360 mg·mL−1 in order to precipitate the protein. The
solution was stirred for 30 min at 4 °C and centrifuged again at
22 000g. The resulting pellet was resuspended in 25 mM Tris-HCl, at
pH 7.7, and dialyzed against the same buffer to remove salts. The
dialyzed solutions were then loaded onto an anion exchange column
(26/10 Q Sepharose high performance, GE Healthcare, Little
Chalfont, UK), eluted with a 0−1 M NaCl step gradient, and then
further purified by loading onto a size exclusion column (Hiload 26/
60 Superdex 75 preparation grade, GE Healthcare, Little Chalfont,
UK). All fractions containing the monomeric protein were pooled
together and concentrated by using Vivaspin filter devices (Sartorius
Stedim Biotech, Gottingen, Germany). Protein purity was analyzed by
SDS-PAGE, and protein concentrations were determined spectro-
photometrically using ε275 = 5600 M
−1 cm−1.
Preparation of αS Oligomers. Toxic αS oligomeric samples
were prepared as previously described.19 Briefly, 6 mg of lyophilized
protein was resuspended in PBS buffer at a pH of 7.4 and at a
concentration of 12 mg·mL−1. The solution was passed through a 0.22
μm cutoff filter and subsequently incubated at 37 °C for 24 h in
stationary mode and without agitation in order to avoid acceleration
of fibril formation.19 Residual fibrillar species were removed by
ultracentrifugation for 1 h at 288 000g using a TLA-120.2 Beckman
rotor (Beckman Coulter, Brea, CA USA). The excess of αS
monomers in the sample was then removed by means of several
filtration steps using 100 kDa cutoff membranes, which resulted in the
enrichment of the oligomeric αS species. Samples of the toxic αS
oligomers prepared in this manner have been found to be stable for
many days but in this study were used within 2 days of their
production. Fluorescently labeled αS molecules carrying the AF488
dye (Invitrogen, Carlsbad, CA, USA) were obtained by using the
N122C mutational variant, allowing the dye molecules to react with
the thiol moiety of Cys122.18 The labeled protein was then purified
from the excess of free dye by a P10 desalting column with a
Sephadex G25 matrix (GE Healthcare, Waukesha, WI, USA) and
concentrated using Amicon Ultra Centricons (Merck, Darmstadt,
Germany). Fluorescent oligomers were generated by mixing 90% and
10% of unlabeled and labeled αS, respecitvely. The low ratio of
labeled to unlabeled monomers and the C-terminal position of
Cys122, which is not involved in oligomer formation and membrane
interaction,17 ensured the absence of significant modifications to the
properties of the oligomers.
Incubation of αS Oligomers with Antibodies. Nt-Ab (128003,
Synaptic Systems, Gottingen, Germany) is a polyclonal rabbit
antibody generated against a synthetic peptide spanning residues 2
to 25 in human αS. Ct-Ab (128211, Synaptic Systems, Gottingen,
Germany) is a monoclonal mouse antibody generated against the
synthetic peptide spanning residues 126 to 140 in human αS. All the
experiments reported in this study were based on direct incubation of
the αS oligomers (0.3 μM monomer equivalents) with an equimolar
concentration of the antibodies (either Nt-Ab or Ct-Ab), using rat
primary cortical neurons or human neuroblastoma SH-SY5Y cells. In
a series of experiments, αS oligomers (0.3 μM monomer equivalents)
were added to the cells in the presence of different concentrations of
antibodies (from 0.03 μM to 0.3 μM), with αS/Ab molar ratios of
1:0.1, 1:0.25, 1:0.5, and 1:1. We also tested a protocol involving a
preincubation of 1 h of the αS oligomers (0.3 μM monomer
equivalents) with an equimolar concentration of the antibodies
(either Nt-Ab or Ct-Ab) in the cell medium, and subsequent addition
of this mixture to the neuronal cell lines, generating results that are
undistinguishable from those obtained with the first protocol.
Cell Cultures. Primary rat cortical neurons were obtained from
embryonic day (ED)-17 Sprague−Dawley rats (Harlan) as described
in ref 57. The experimental procedures were in accordance with the
standards defined in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Sciences, National
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Academy Press, Washington, DC). Cortical neurons were maintained
in neuronal basal medium (NBM) at 37 °C in a 5.0% CO2-humidified
atmosphere and analyzed 14 days after plating, as previously
described.22,58 Authenticated human neuroblastoma SH-SY5Y cells
were purchased from A.T.C.C. (Manassas, VA, USA). The cells were
tested to ensure that they were free from mycoplasma contamination
and were cultured in Dulbecco’s modified Eagle’s medium (DMEM),
F-12 HAM with 25 mM HEPES, and NaHCO3 (1:1) and
supplemented with 10% FBS, 1 mM glutamine, and 1.0% anti-
biotics.57−59 Cell cultures were maintained in a 5% CO2 humidified
atmosphere at 37 °C and grown until they reached 80% confluence
for a maximum of 20 passages.22,58−61
Cellular Membrane Permealization by Calcein-Derived
Fluorescence. Primary rat cortical neurons and SH-SY5Y cells
were plated on glass coverslips and treated for 10 min at 37 °C with
1.0 μM calcein-AM (Molecular Probes, Eugene, Oregon) diluted in
culture medium, as previously described.22,61,62 The levels of
intracellular calcein-derived fluorescence at 488 nm were then
measured using confocal microscopy following incubation of the
two types of cells with αS oligomers for 1 h at a concentration of 0.3
μM (monomer equivalents) in the absence or presence of an
equimolar concentration of either Nt-Ab or Ct-Ab. Cell fluorescence
was analyzed by a TCS SP5 scanning confocal microscopy system
(Leica Microsystems, Mannheim, Germany) equipped with an argon
laser source, using the 488 nm excitation line. A series of 1.0-μm-thick
optical sections (1024 × 1024 pixels) was taken through the cells for
each sample using a Leica Plan Apo 63× oil immersion objective and
then projected as a single composite image by superimposition. The
confocal microscope was set at optimal acquisition conditions, e.g.,
pinhole diameters, detector gain and laser powers. The settings were
maintained at constant values for each analysis.
Imaging and Quantification of αS Oligomers Bound to the
Plasma Membrane. Primary cortical neurons or SH-SY5Y cells
were seeded on glass coverslips and treated for 15 min with αS
oligomers at a concentration of 0.3 μM (monomer equivalents) with
or without an equimolar concentration of either Nt-Ab or Ct-Ab. In
each series of experiments, αS oligomers were added to SH-SY5Y cells
in the absence or presence of different concentrations of Nt-Ab (from
0.03 μM to 0.3 μM). The αS/Ab molar ratios were 1:0.1, 1:0.25,
1:0.5, and 1:1. After incubation, the cells were washed with PBS and
counterstained for 15 min using 5.0 μg mL−1 of Alexa Fluor 633-
conjugated wheat germ agglutinin in order to label fluorescently the
plasma membrane (Life Technologies, Carlsbad CA, USA).17,22,35
After washing with PBS, the cells were fixed in 2% (w/v) buffered
paraformaldehyde for 10 min at RT (20 °C). αS oligomers were
detected using 1:250 diluted mouse monoclonal anti-αS IgG1
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or
with 1:250 diluted rabbit polyclonal anti-αS antibodies (Life
Technologies, Carlsbad CA, USA) that were coupled with 1:1000
diluted Alexa Fluor 488-conjugated antimouse or antirabbit secondary
antibodies (Life Technologies, Carlsbad CA, USA). To detect only
the oligomers bound to the cell surface, the cellular membrane was
not permeabilized at this stage, thus preventing antibody internal-
ization. Fluorescence emission was detected after double excitation at
633 and 488 nm by the scanning confocal microscopy system
described above and a series of 1.0-μm-thick optical sections were
projected as a single composite image by superimposition. In another
series of experiments, AF488 αS oligomers (0.3 μM monomer
equivalents) were also added to the cells with an equimolar
concentration of the antibodies (either Nt-Ab or Ct-Ab) for 15
min. The cells were washed with PBS and counterstained with Alexa
Fluor 633-conjugated wheat germ agglutinin and analyzed by confocal
microscopy as described above.
MTT Reduction Assay. αS oligomers at a concentration of 0.3
μM (monomer equivalents) in the absence or presence of either Nt-
Ab or Ct-Ab were added to the cell culture medium of primary rat
cortical neurons or SH-SY5Y cells, seeded in 96-well plates, for 24 h.
The αS/Ab molar ratios were 1:0.1, 1:0.25, 1:0.5, and 1:1. The MTT
reduction assay was performed as previously described.22,58−61
ROS Measurements. αS oligomers at a concentration of 0.3 μM
(monomer equivalents) in the absence or presence of an equimolar
concentration of either Nt-Ab or Ct-Ab were added to the cell culture
medium of primary rat cortical neurons or SH-SY5Y cells and seeded
on glass coverslips for 15 min. Cells were loaded with 10 μM 2′,7′-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Life Technol-
ogies, CA, USA) as previously described.22,59 Cell fluorescence was
analyzed by the confocal microscopy system described above.
ThT and ANS Fluorescence. Fluorescence measurements were
performed using a 3 × 3 mm quartz cell and a PerkinElmer LS 55
spectrofluorimeter (Waltham, MA, USA) equipped with a thermo-
stated cell holder attached to a ThermoHaake C25P water bath
(Karlsruhe, Germany). ThT fluorescence was monitored by exciting
the sample at 440 nm and recording the emission fluorescence
spectrum between 460 and 600 nm. αS oligomers (4 μM) were
incubated in the absence or presence of an equimolar ratio of Nt-Ab
for 15 min with 10 μM ThT in PBS, 25 °C, before performing the
measurement. ANS fluorescence was monitored by exciting the
sample at 350 nm and recording the emission spectrum between 400
to 650 nm. αS oligomers (4 μM) were incubated in the absence or
presence of an equimolar ratio of Nt-Ab for 15 min with 150 μM ANS
and PBS, 25 °C, before recording the spectra.
C. elegans Cultures. The following C. elegans strains were used:
zgIs15 [P(unc-54)::αS::YFP]IV (OW40) and rmIs126 [P(unc-
54)Q0::YFP]V (OW450), kindly provided by Prof. Ellen Nollen
(University of Groningen, The Netherlands). The animals were
synchronized by hypochlorite bleaching, hatched overnight in M9
buffer (3 g/L KH2PO4, 6 g/L Na2HPO4, 5 g/L NaCl, 1 μM MgSO4),
and subsequently cultured at 20 °C on nematode growth medium
(NGM; 1 mM CaCl2, 1 mM MgSO4, 5 μg mL
−1 cholesterol, 250 μM
KH2PO4 pH 6, 17 g/L Agar, 3 g/L NaCl, 7.5 g/L casein) in plates
seeded with the E. coli strain OP50. Saturated cultures of OP50 were
grown by inoculating 50 mL of LB medium (10 g/L tryptone, 10 g/L
NaCl, 5g/l yeast extract) with OP50 and incubating the culture for 16
h at 37 °C.38−40 NGM plates were seeded with bacteria by adding 350
μL of saturated OP50 to each plate and leaving the plates at 20 °C for
2−3 days. Worms were transferred from seeded NGM plates on day
3, after synchronization, to the multiwell plates. All the worms were
suspended in a solution of S Medium at 75 worms/mL containing 5
mg mL−1 OP50 as a constant food source. On day 4 after
synchronization, when the worms had reached the L4 stage, 75 μM
5-fluoro-2′-deoxy-uridine (FUDR) was introduced to prevent the
development of future generations. On the same day, Nt-Ab or Ct-Ab
was added to the wells at a concentration of 0.4 μM.
Automated C. elegans Motility Assays. Automated motility
assays58 in multiwells were performed by placing OP50 worms on a
benchtop plate shaker at 750 rpm for 2 min to distribute them evenly.
Immediately after shaking, the worms were staged on the platform for
imaging, and collection was initiated 60 s after shaking. Up to 200
animals were counted in each experiment. This protocol was adapted
from ref 63 and optimized for analysis of motility.
Determination of YFP-αS Inclusions in C. elegans. Individual
animals were mounted on 2% agarose pads, containing 40 mM NaN3
as an anesthetic, on glass microscope slides for imaging.
Quantification of the number of inclusions in YFP-αS animals was
performed only for the frontal region of the worms38 as described
previously64 using a Leica MZ16 FA fluorescence dissection
stereomicroscope (Leica Microsystems, Wetzlar, Germany) at a
nominal magnification of 20×, images were acquired using an
Evolve512 Delta EMCCD Camera, with high quantum efficiency
(Photometrics, Tucson, AZ, USA). Measurements on inclusions were
performed using ImageJ software (National Institutes of Health,
Bethesda, MD, USA). At least 50 animals were examined for each
condition. All experiments were carried out in triplicate, and the data
from one representative experiment are shown in the figure.
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(55) Dioǵenes, M. J., Rombo, D. M., Vicente Miranda, H., Maiolino,
F., Guerreiro, P., Nas̈ström, T., Franquelim, H. G., Oliveira, L. M.,
Castanho, M. A., Lannfelt, L., Bergström, J., Ingelsson, M., Quintas,
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